TFP
RVLP

Tilia Fiduciary Partners’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Tilia Fiduciary Partners’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-435
Closed -$1K – 535
2022
Q3 		$1K Buy
+435
New +$845 ﹤0.01% 505

Other funds holding RVLP

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Tilia Fiduciary Partners's RVLP Position: Q4 2022 in Review

Tilia Fiduciary Partners sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2022, closing a stake of 435 shares — an estimated $1K sold.

Tilia Fiduciary Partners first reported a position in RVLP in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 36 funds tracked by Wall St. Rank hold RVLP as of Q4 2022.

  • Tilia Fiduciary Partners reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Tilia Fiduciary Partners sold 435 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2022, an estimated $1K.
  • Tilia Fiduciary Partners first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q3 2022 and held it in 1 quarter.
  • Tilia Fiduciary Partners's RVL Pharmaceuticals plc Ordinary Shares position peaked at $1K in Q3 2022.
  • 36 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2022.

Based on Tilia Fiduciary Partners's 13F filing for Q4 2022, filed 10 Feb 2023.